Recent development in mammalian sialidase molecular biology

Neurochemical Research

Volumn 27, Issue 7-8, 2002, Pages 649-663

  Monti, E ^a   Preti, A ^a   Venerando, B ^b   Borsani, G ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b LITA   (Italy)

Author keywords

Gene structure and expression; Mammalian sialidase; Molecular cloning; Molecular properties; Transgenic expression

Indexed keywords

COMPLEMENTARY DNA; GANGLIOSIDE; GLYCOLIPID; GLYCOPROTEIN; POLYSACCHARIDE; SIALIDASE;

AMINO ACID SEQUENCE; CELLULAR DISTRIBUTION; ENZYME ANALYSIS; GALACTOSIALIDOSIS; GENE EXPRESSION; GENE STRUCTURE; HUMAN; LYSOSOME STORAGE DISEASE; MOLECULAR CLONING; MULTIGENE FAMILY; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SIALIDOSIS; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELL MEMBRANE; CLONING, MOLECULAR; HUMANS; MAMMALS; MOLECULAR SEQUENCE DATA; MUCOLIPIDOSES; MUTAGENESIS, SITE-DIRECTED; NEOPLASMS; NEURAMINIDASE; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

MAMMALIA;

EID: 0036694820     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020276000901     Document Type: Review

References (91)

1. Saito, N. and Yu, R. K. 1995. Biochemistry and function of sialidases. Pages 261-313 in Rosemberg, A. (ed.), Biology of Sialic Acids, Plenum Press, New York and London.
2. Gubareva, L. V., Kaiser, L., and Hayden, F. G. 2000. Influenza virus neuraminidase inhibitors. Lancet, 355:827-835.
3. Thomas, G. H. 2001. Disorders of glycoprotein degradetion: α-mannosidosis, β-mannosidosis, fucosidosis and sialidosis. Pages 3507-3534, in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), The Metabolic and Molecular Bases of Inherited Disease, vol III, 8th ed., McGraw-Hill, New York.
4. D'Azzo, A., Andria, G., Strisciuglio, P., and Galjaard, H. 2001. Galactosialidosis. Pages 3811-3826, in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), The Metabolic and Molecular Bases of Inherited Disease, vol III, 8th ed., McGraw-Hill, New York.
5. Achyuthan, K. E. and Achyuthan, A. M. 2001. Comparative enzymology, biochemistry and pathophysiology of human exo-α-sialidases (neuraminidases). Comp. Biochem. Physiol. Part B, 129:29-64.
6. Miyagi, T., Konno, K., Emori, Y., Kawasaki, H., Suzuki, K., Yasui, A., and Tsuik, S. 1993. Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase. J. Biol. Chem., 268:26435-26440.
7. Roggentin, P., Rothe, B., Kaper, J., Galen, J., Lawrisuk, L., Vimr, E., and Schauer, R. 1989. Conserved sequences in bacterial and viral sialidases. Glycoconj. J., 6:349-353.
8. Ferrari, J., Harris, R., and Warner, T. G. 1994. Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: Sequence alignment similarities to bacterial sialidases. Glycobiology, 4:367-373.
9. Potier, M., Yan, D., and Womack, J. 1979. Neuraminidase deficiency in the mouse. FEBS Lett. 108:345-348.
10. Womack, J., Yan, D., and Potier, M. 1981. Gene for neuraminidase activity on mouse chromosome 17 near H-2: Pleiotropic effect on multiple hydrolases. Science 212:63-65.
11. Samollow, P., VandeBerg, J., Ford, A., Douglas, T., and David, C. 1986. Electrophoretic analysis of liver neuraminidase-1 variation in mice and additional evidence concerning the location of NEU-1. J. Immunogenet. 13:29-39.
12. Harada, F., Nishimura, Y., Suzuki, K., Matsumoto, H., Oohira, T., Matsuda, I., and Sasazuki, T. 1987. The patient with combined deficiency of neuraminidase and 21-hydroxylase. Hum. Genet. 75:91-92.
13. Campbell, R. D. and Trowsdale, J. 1993. Map of the human MHC. Immunol Today. 14:349-352.
14. Milner, C., Smith, S., Carrillo, M., Taylor, G., Hollinshead, M., and Campbell, R. 1997. Identification of a sialidase encoded in the human major histocompatibility complex. J. Biol. Chem. 272:4549-4558.
15. Bonten, E., van der Spoel, A., Fornerod, M., Grosveld, G., and d'Azzo, A. 1996. Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev. 10:3156-3169.
16. Pshezhetsky, A., Richard, C., Michaud, L., Igdoura, S., Wang, S., Elsliger, M., Qu, J., Leclerc, D., Gravel, R., Dallaire, L., and Potier, M. 1997. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat. Genet. 15:316-320.
17. Boguski, M. S. and Schuler, G. D. 1995. ESTablishing a human transcript map. Nat. Genet. 10:369-373.
18. Carrillo, M. B., Milner, C. M., Ball, S. T., Snoek, M., and Campbell, R. D. 1997. Glycobiology 7:975.
19. Igdoura, S. A., Gafuik, C., Mertineit, C., Saberi, F., Pshezhetsky, A., Potier, M., Trasler, J., and Gravel, R. 1998. Cloning of the cDNA and gene encoding mouse lysososmal sialidase and correction of sialidase deficiency in human sialidosis and mouse SM/J fibroblasts. Hum. Mol. Genet. 7:115-121.
20. Rottier, R., Bonten, E., and d'Azzo, A. 1998. A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse. Hum. Mol. Genet. 7:313-321.
21. Monti, E., Preti, A., Rossi, E., Ballabio, A., and Borsani, G. 1999. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics 57:137-143.
22. Monti, E., Preti, A., Nesti, C., Ballabio, A., and Borsani, G. 1999. Expression of a novel human sialidase encoded by the NEU2 gene. Glycobiology 9:1313-1321.
23. Hata, K., Wada, T., Hasegawa, A., Kiso, M., and Miyagi, T. 1998. J. Biochem. 248:527-544.
24. Miyagi, T. Wada, T., Iwamatsu, A., Hata, K., Yoshikawa, Y., Tokuyama, S., and Sawada, M. 1999. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J. Biol. Chem. 274:5004-5011.
25. Wada, T., Yoshikawa, Y., Tokuyama, S., Kuwabara, M., Akida, H., and Miyagi, T. 1999. Cloning, expression, and chromosomal mapping od a human ganglioside sialidase. Biochem. Biophys. Res. Commun. 261:21-27.
26. Monti, E., Bassi, M. T., Papini, N., Riboni, M., Manzoni, M., Venerando, B., Croci, G. L., Preti, A., Ballabio, A., Tettamanti, G., and Borsani, G. 2000. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem. J. 349:343-351.
27. Fronda, C. L., Zeng, G., Gao, L., and Yu, R. K. 1999. Molecular cloning and expression of mouse brain sialidase. Biochem. Biophys. Res. Commun. 258:727-731.
28. Hasegawa, T., Yamaghchi, K., Wada, T., Takeda, A., Itoyama, Y., and Miyagi, T. 2000. Molecular cloning of mause ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J. Biol. Chem. 275:8007-8015.
29. Hasegawa, T., Feijoo Carnero, C., Wada, T., Itoyama, Y., and Miyagi, T. 2001. Differential expression of three sialidase genes in rat development. Biochem. Biophys. Res. Commun. 280: 726-732.
30. Miyagi, T., Wada, T., and Yamaguchi, K. 1999. Multiple forms of mammalian sialidase and their altered expression in physiological and pathological conditions. Pages 197-205, in Inoue, Y., Lee, Y. C., and Troy, F. A., II (eds.), Sialobiology and Other Novel Forms of Glycosylation. Gagushin Publishing Co.
31. Sato, K. and Miyagi, T. 1995. Genomic organization and the 5′upstream sequence of the rat cytosolic sialidase gene. Glycobiology 5:511-516.
32. Murre, C., McCaw, P. S., and Baltimore, D. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, duaghterless, myoD, and Myc proteins. Cell 56:777-784.
33. Crennell, S. J., Garman, E. F., Laver, W. G., Vimr, E. R., and Taylor, G. L. (1993) Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. Proc. Natl. Acad. Sci. U.S.A. 90:9852-9856.
34. Hoyer, L. L., Hamilton, A. C., Steenbergen, S. M., and Vimr, E. R. 1992. Cloning, sequencing and distribution of the Salmonella typhimurium LT2 sialidase gene, nanH, provides evidence for interspecies gene transfer. Mol. Microbiol. 6:873-874.
35. Wang, Y., Yamaguchi, K., Shimada, Y., Zhao, X., and Miyagi, T. 2001. Site-directed mutagenesis of human membrane-associated ganglioside sialidase: Identification of amino-acid residues contributing to substrate specificity. Eur. J. Biochem. 268: 2201-2208.
36. Burmeister, W. P., Henrissat, B., Bosso, C., Cusack, S., and Ruigrok, R. W. 1993. Influenza B virus neuraminidase can synthesize its own inhibitor. Structure 1:19-26.
37. Roggetin, T., et al. 1992. Glycoconj. J. 9:235-240.
38. Taylor, G. 1996. Sialidases: Structures, biological significance and therapeutic potential. Curr. Opin. Struct. Biol. 6:830-837.
39. Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., and Proia, R. 1995. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 11:170-176.
40. Li, S.-C., Li, Y.-T., Moriya, S., and Miyagy, T. 2001. Degradation of GM1 and GM2 by mammalian sialidase. Biochem. J. 360:233-237.
41. Gravel, R. A., Clarke, J. T. R., Kaback, M. M., Mahuran, D., Sandhoff, K., and Suzuki, K. 1995. The GM2 gangliosidosis. Pages 2839-2879, in Schriver, C. W., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), Metabolic Basis of Inherited Diseases. McGraw-Hill Book Co, New York.
42. Wu, Y. Y., Lockyer, J. M., Sugiyama, E., Pavlova, N. V., Li, Y.-T., and Li, S.-C. 1994. Expression and specificity of human GM2 activator protein. J. Biol. Chem. 269:16276-16283.
43. Crennell, S., Garman, E., Laver, Vimr, E., and Taylor, G. L. 1994. Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure 2:535-544.
44. Varghese, J. N., Laver, W. G., and Colman, P. M. 1983. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature. 303:35-40.
45. Burmeister, W. P., Ruigrok, R. W., and Cusack, S. 1992. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J. 11:49-56.
46. Crennell, S., Takimoto, T., Portner, A., and Tailor, G. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7:1068-1074.
47. Kao, Y. H., Lerner, L., and Warner, T. G. 1997. Stereoselectivity of the Chinese hamster ovary cell sialidase: Sialoside hydrolysis with overall retention of configuration. Glycobiology 7: 559-563.
48. Gebler, J., Gilkes, N. R., Claeyssens, M., Wilson, D. B., Beguin, P., Wakarchuk, W. W., Kilburn, D. G., Miller, R. C., Jr., Warren, R. A., and Withers, S. G. 1992. Stereoselective hydrolysis catalyzed by related beta-1,4-glucanases and beta-1,4-xylanases. J. Biol. Chem. 267:12559-12561.
49. Olson, E. and Klein, W. 1994. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
50. Sato, K. and Miyagi, T. 1996. Involvement of an endogenous sialidase in skeletal muscle cell differentiation. Biochem. Biophys. Res. Commun. 221:826-830.
51. Akita, H., Miygi, T., Hata, K., and Kagayama, M. 1997. Immunohistochemical evidence for the existence of rat cytosolic sialidase in rat skeletal muscles. Histochem. Cell. Biol. 107: 495-503.
52. Tokuyama, S., Moriya, S., Taniguchi, S., Yasui, A., Miyazaki, J., Orikasa, S., and Miyagi, T. 1997. Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA. Int. J. Cancer. 73:410-415.
53. Gillard, B. K., Thurmon, L. T., and Marcus, D. M. 1993. Variable subcellular localization of glycosphingolipids. Glycobiology 3:57-67.
54. Sawada, M., Moriya, S., Saito, S., Shineha, R., Satomi, S., Yamori, T., Tsuruo, T., Kannagi, R., and Miyagi, T. 2002. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int. J. Cancer 97:180-185.
55. Kato, T., Wang, T., Yamaguchi, K., Milner, C. M., Shineha, R., Satomi, S., and Miyagi, T. 2001. Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine melanoma cells. Int. J. Cancer 92:797-804.
56. Pshezhetsky, A. V. and Potier, M. 1996. Association of Nacetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate. J. Biol. Chem. 271:28359-28365.
57. Hiraiwa, M., Saitoh, M., Arai, N., Shiraishi, T., Odani, S., Uda, Y., Ono, T., and O'Brien, J. S. 1997. Protective protein in the bovine lysosomal beta-galactosidase complex. Biochim. Biophys. Acta 1341:189-199.
58. Bonten, E. J. and d'Azzo, A. 2000. Lysosomal neuraminidase. Catalytic activation in insect cells is controlled by the protective protein/cathepsin A. J. Biol. Chem. 275:37657-37663.
59. Vinogradova, M. V., Michaud, L., Mezentsev, A. V., Lukong, K. E., El-Alfy, M., Morales, C. R., Potier, M., and Pshezhetsky, A. V. 1998. Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation. Biochem. J. 330:641-650.
60. Naraparaju, V. R. and Yamamoto, N. 1994. Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages. Immunol. Lett. 43:143-148.
61. Chen, X. P., Enioutina, E. Y., and Daynes, R. A. 1997. The control of IL-4 gene expression in activated murine T lymphocytes: A novel role for neu-1 sialidase. J. Immunol. 158:3070-3080.
62. Chen, X. P., Ding, X., and Daynes, R. A. 2000. Ganglioside control over IL-4 priming and cytokine production in activated T cells. Cytokine 12:972-985.
63. Lukong, K. E., Seyrantepe, V., Landry, K., Trudel, S., Ahmad, A., Gahl, W. A., Lefrancois, S., Morales, C. R., and Pshezhetsky, A. V. 2001. Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. J. Biol. Chem. 276:46172-46181.
64. Jarousse, N. and Kelly, R. B. 2000. Selective inhibition of adaptor complex- mediated vesiculation. Traffic 1:378-384.
65. Dell'Angelica, E. C., Shotelersuk, V., Aguilar, R. C., Gahl, W. A., and Bonifacino, J. S. 1999. Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol. Cell. 3:11-21.
66. Ostrov, D. A., Shi, W., Schwartz, J. C., Almo, S. C., and Nathenson, S. G. 2000. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 290:816-819.
67. Lukong, K. E., Elsliger, M.-A., Chang, Y., Richard, C., Thomas, G., Carey, W., Tylki-Szymanska, A., Czartoryska, B., Buchholz, T., Rodriguez Criado, G., Palmeri, S., and Pshezhetsky, A. V. 2000. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex. Hum. Mol. Genet. 9:1075-1085.
68. Bonten, E. J., Arts, W. F., Beck, M., Covanis, A., Donati, M. A., Parini, R., Zammarchi., E., and d'Azzo, A. 2000. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Hum. Mol. Genet. 9:2715-2725.
69. Naganawa, Y., Itoh, K., Shimmoto, M., Takiguchi, K., Doi, H., Nishizawa, Y., Kobayashi, T., Kamei, S., Lukong, K. E., Pshezhetsky, A. V., and Sakuraba, H. 2000. Molecular and structural studies of Japanese patients with sialidosis type 1. J. Hum. Genet. 45:241-249.
70. Penzel, R., Uhl, J., Kopitz, J., Beck, M., Otto, H. F., and Cantz, M. 2001. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient. FEBS Lett. 501:135-138.
71. Sergi, C., Penzel, R., Uhl, J., Zoubaa, S., Dietrich, H., Decker, N., Rieger, P., Kopitz, J., Otto, H. F., Kiessling, M., and Cantz, M. 2001. Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) gene. Hum. Genet. 109:421-428.
72. Itoh, K., Naganawa, Y., Matsuzawa, F., Aikawa, S., Doi, H., Sasagasako, N., Yamada, T., Kira, J., Kobayashi, T., Pshezhetsky, A. V., and Sakuraba, H. 2002. Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes. J. Hum. Genet. 47:29-37.
73. Lukong, K. E., Landry, K., Elsliger, M. A., Chang, Y., Lefrancois, S., Morales, C. R., and Pshezhetsky, A. V. 2001. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex. J. Biol. Chem. 276:17286-17290.
74. Preti, A., Fiorilli, A., Lombardo, A., Caimi, L., and Tettamanti, G. 1980. Occurrence of sialyltransferase activity in the synaptosomal membranes prepared from calf brain cortex. J. Neurochem. 35:281-296.
75. Tettamanti, G. and Riboni, L. 1993. Gangliosides and modulation of the function of neural cells. Adv. Lipid Res. 25:235-267.
76. Kopitz, J., von Reitzenstein, C., Muhl, C., and Cantz, M. 1994. Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation. Biochem. Biophys. Res. Commun. 199:1188-1193.
77. Kopitz, J., von Reitzenstein, C., Sinz, K., and Cantz, M. 1996. Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells. Glycobiology 6:367-376.
78. Kopitz, J., Oehler, C., and Cantz, M. 2001. Desialylation of extracellular GD1a-neoganglioprotein suggests cell surface orientation of the plasma membrane-bound ganglioside sialidase activity in human neuroblastoma cells. FEBS Lett. 491:233-236.
79. Kalka, D., von Reitzenstein, C., Kopitz, J., and Cantz, M. 2001. The plasma membrane ganglioside sialidase cofractionates with markers of lipids rafts. Biochem. Biophys. Res. Commun. 283: 989-993.
80. Simon, K. and Ikonen, E. 1997. Functional rafts in cell membranes. Nature 387:569-572.
81. Brown, D. A. and London, E. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275:17221-17224.
82. Saito, M. and Yu, R. K. 1992. Role of myelin-associated neuraminidase in the ganglioside metabolism of rat brain myelin. J. Neurochem. 58:83-87.
83. Pitto, M., Chigorno, V., Giglioni, A., Valsecchi, M., and Tettamanti, G. 1989. Sialidase in cerebellar granule cells differentiating in culture. J. Neurochem. 53:1464-1470.
84. Wu, G. and Ledeen, R. W. 1991. Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: Putative role of GM1 ganglioside in differentiation. J. Neurochem. 56: 95-104.
85. Saito, M., Tanaka, Y., Tang, C. P., Yu, R. K., and Ando, S. 1995. Characterization of sialidase activity in mouse synaptic plasma membranes and its age-related changes. J. Neurosci. Res. 40: 401-406.
86. Rodriguez, J. A., Piddini, E., Hasegawa, T., Miyagi, T., and Dotti, C. G. 2001. Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture. J. Neurosci. 21:8387-8395.
87. Hata, K., Sasaki, A., Sawada, M., Wada, T., Tateno, H., and Miyagi, T. 2001. Overexpression of ganglioside sialidase in transgenic mice leads to non-insulin dependent diabetes mellitus. Glycoconj. J. 18:90.
88. Chiarini, A., Fiorilli, A., Di Francesco, L., Venerando, B., and Tettamanti, G. 1993. Human erythrocyte sialidase is linked to the plasma membrane by a glycosylphosphatidylinositol anchor and partly located on the outer surface. Glycoconj. J. 10: 64-71.
89. Venerando, B., Fiorilli, A., Croci, G. L., and Tettamanti, G. 1997. Presence in human erythrocyte membranes of a novel form of sialidase acting optimally at neutral pH. Blood 90:2047-2056.
90. Tringali, C., Fiorilli, A., Venerando, B., and Tettamanti, G. 2001. Different behavior of ghost-linked acidic and neutral sialidases during human erythrocyte ageing. Glycoconj. J. 18: 407-418.
91. Venerando, B., Fiorilli, A., Croci, G. L., Trincali, C., Goi, G., Mazzanti, L., Curatola, G., Segalini, G., Massaccesi, L., Lombardo, A., and Tettamanti, G. 2002. Acidic and neutral sialidase in the erythrocyte membrane of type 2 diabetic patients. Blood 99:1064-1070.